Is Standard Biotools Inc (LAB) a Winner in the Healthcare Sector?

Standard Biotools Inc (LAB) is around the top of the Healthcare sector according to InvestorsObserver. LAB received an overall rating of 63, which means that it scores higher than 63% of stocks. Additionally, Standard Biotools Inc scored a 90 in the Healthcare sector, ranking it higher than 90% of stocks in that sector.

LAB has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on LAB!

See Full LAB Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 63 would rank higher than 63 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Standard Biotools Inc Stock Today?

Standard Biotools Inc (LAB) stock is trading at $2.08 as of 10:05 AM on Thursday, Oct 5, a decline of -$0.02, or -1.19% from the previous closing price of $2.10. The stock has traded between $2.04 and $2.17 so far today. Volume today is light. So far 233,725 shares have traded compared to average volume of 466,812 shares. Click Here to get the full Stock Report for Standard Biotools Inc stock.